Paradigm Biopharmaceuticals |
Market Cap (21-Jul) $96,499,192 (477th) |
Close (30-Jun) $0.99 |
Volume (30-Jun) 1,077,429 |
Shortsold (14-Jul) 23,505 (0.00%) (596th) |
|
52w High $0.470 |
52w Low $0.135 |
P/E 8.12 |
EPS -0.1 |
[ARTICLE] Paradigm Biopharmaceuticals blues with Morgans
A news article has been posted about Paradigm Biopharmaceuticals on the AFR. The article was published around , on 13 March 2022 at 4:05pm.
Any Morgans clients who moved quickly on the retail broker’s advice to dump Paradigm Biopharmaceuticals must be ruing their timing.
Read ArticlePAR was $1.20 at the close of trade on 11 March 2022
| Recent Articles about ASX:PAR | |
|---|---|
| 19-Jul | Form 605 - HotCopper
company-announcements.afr.com |
| 17-Jul | Appendix 2A - Application for quotation of securities - AFR
company-announcements.afr.com |
| 13-Jul | Appendix 3G - Notification of issue, conversion or payment up ... - AFR
company-announcements.afr.com |
| 13-Jul | Drawdown of Tranche 4 under the Convertible Note Facility - AFR
company-announcements.afr.com |
| 13-Jul | ASX RELEASE 13 July 2026 Cleansing Notice - AFR
company-announcements.afr.com |
| 6-Jul | Appendix 3Y - AFR
company-announcements.afr.com |
| 29-Jun | Appendix 3H - Notification of cessation of securities - AFR
company-announcements.afr.com |
| 20-Jun | Appendix 3Y - AFR
company-announcements.afr.com |
| 20-Jun | Change of Director's Interest Notice - 05 Jun 2026 - Market Index
company-announcements.afr.com |
| 20-Jun | Appendix 3Y - AFR
company-announcements.afr.com |
| Tracked |
Find all articles about Paradigm Biopharmaceuticals, including others on the AFR, on the media page.
You must be logged in to post a reply.